![Aust Business Solutions Cards[361].png](https://static.wixstatic.com/media/998043_718980c66bad41918f49ecf64f206fe2~mv2.png/v1/crop/x_0,y_55,w_1004,h_481/fill/w_215,h_103,al_c,q_85,usm_0.66_1.00_0.01,enc_auto/Aust%20Business%20Solutions%20Cards%5B361%5D.png)
Lots has been happening in the Lipid Nanoparticle Market. Here's the latest from October: 17 patent publications this month (40% of which mention mRNA or RNA), a licensing deal between Omega Therapeutics and Nitto Denko Corporation for Nitto Denko Corporation's LNP technology, published success of a synthetic vRNA/LNP platform, and more.
Check it out and be on the lookout for the November issue in the beginning of December.
Download a copy of the Market Analysis below.
October LNP Market Analysis v2_blog
.pdf
Download PDF • 2.95MB